NIH Starts Clinical Trial Of Shionogi’s COVID-19 Antiviral In Hospitalized Patients

Reuters (2/16, Sunny) reports, “The U.S. National Institutes of Health (NIH) said on Wednesday that it had started a clinical trial to evaluate Japan’s Shionogi & Co Ltd’s experimental oral antiviral drug to treat COVID-19.” This “drug, S-217622 or ensitr...